These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2578898)

  • 21. Delayed onset bleomycin-induced pneumonitis.
    Uzel I; Ozguroglu M; Uzel B; Kaynak K; Demirhan O; Akman C; Oz F; Yaman M
    Urology; 2005 Jul; 66(1):195. PubMed ID: 15992893
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum creatinine level during chemotherapy for testicular cancer as a possible predictor of bleomycin-induced pulmonary toxicity.
    Kawai K; Hinotsu S; Tomobe M; Akaza H
    Jpn J Clin Oncol; 1998 Sep; 28(9):546-50. PubMed ID: 9793027
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Angiotensin-converting enzyme inhibition restores the diffusing capacity for carbon monoxide in patients with chronic heart failure by improving the molecular diffusion across the alveolar capillary membrane.
    Guazzi M; Agostoni P
    Clin Sci (Lond); 1999 Jan; 96(1):17-22. PubMed ID: 9857102
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantitative assessment of lung damage due to bleomycin using computed tomography.
    Bellamy EA; Nicholas D; Husband JE
    Br J Radiol; 1987 Dec; 60(720):1205-9. PubMed ID: 2446690
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of diffusing capacity in patients with a restrictive lung disease.
    Stam H; Splinter TA; Versprille A
    Chest; 2000 Mar; 117(3):752-7. PubMed ID: 10713002
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined measurement of carbon monoxide and nitric oxide lung transfer does not improve the identification of pulmonary hypertension in systemic sclerosis.
    Degano B; Soumagne T; Delaye T; Berger P; Perez T; Guillien A; Pellegrin JL; Launay D; Magy-Bertrand N; Agard C; Tiev KP; Hua-Huy T; Tardiff C; Diaz V; Chambellan A; Dinh-Xuan AT
    Eur Respir J; 2017 Oct; 50(4):. PubMed ID: 29051271
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alteration of the alveolar-capillary membrane diffusing capacity in chronic left heart disease.
    Assayag P; Benamer H; Aubry P; de Picciotto C; Brochet E; Besse S; Camus F
    Am J Cardiol; 1998 Aug; 82(4):459-64. PubMed ID: 9723633
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Insulin improves alveolar-capillary membrane gas conductance in type 2 diabetes.
    Guazzi M; Oreglia I; Guazzi MD
    Diabetes Care; 2002 Oct; 25(10):1802-6. PubMed ID: 12351481
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diffusion capacity and haemodynamics in primary and chronic thromboembolic pulmonary hypertension.
    Steenhuis LH; Groen HJ; Koëter GH; van der Mark TW
    Eur Respir J; 2000 Aug; 16(2):276-81. PubMed ID: 10968503
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pulmonary diffusing capacity and capillary blood volume in aging dogs.
    Robinson NE; Gillespie JR
    J Appl Physiol; 1975 Apr; 38(4):647-50. PubMed ID: 1141096
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Body position, membrane diffusing capacity and pulmonary capillary blood volume in chronic bronchitis and pulmonary emphysema.
    Chou KC; Chang SC; Chang HI; Shiao GM
    Zhonghua Yi Xue Za Zhi (Taipei); 1999 Apr; 62(4):209-16. PubMed ID: 10367481
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Membrane and capillary blood components of diffusion capacity of the lung for carbon monoxide in pulmonary sarcoidosis: relation to exercise gas exchange.
    Lamberto C; Nunes H; Le Toumelin P; Duperron F; Valeyre D; Clerici C
    Chest; 2004 Jun; 125(6):2061-8. PubMed ID: 15189922
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effect of pneumothorax on membrane diffusing capacity and pulmonary capillary blood volume].
    Zeng M; Xie C; Li Z
    Zhonghua Jie He He Hu Xi Za Zhi; 1999 Apr; 22(4):242-4. PubMed ID: 11775924
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elevation of the erythrocyte sedimentation rate precedes exacerbation of bleomycin-induced pulmonary toxicity: report of two cases and review of literature.
    Higa GM; AlKhouri N; Auber ML
    Pharmacotherapy; 1997; 17(6):1315-21. PubMed ID: 9399618
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Altered pulmonary gas transfer capacity and capillary blood volume in pediatric Crohn's disease.
    Verstraete M; Choukroun ML; Siao-Him Fa V; Fayon M; Rebouissoux L; Enaud R; Lamireau T
    Pediatr Pulmonol; 2017 Aug; 52(8):1051-1056. PubMed ID: 28719106
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Measurement of carbon monoxide transfer and lung volume in ventilated subjects.
    Macnaughton PD; Morgan CJ; Denison DM; Evans TW
    Eur Respir J; 1993 Feb; 6(2):231-6. PubMed ID: 8444295
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cigarette smoking is a risk factor for bleomycin-induced pulmonary toxicity.
    Senan S; Paul J; Thomson N; Kaye SB
    Eur J Cancer; 1992; 28A(12):2084. PubMed ID: 1384608
    [No Abstract]   [Full Text] [Related]  

  • 38. Carbon monoxide diffusing capacity: a reliable indicator of bleomycin-induced pulmonary toxicity.
    Sørensen PG; Rossing N; Rørth M
    Eur J Respir Dis; 1985 May; 66(5):333-40. PubMed ID: 2410287
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of pulmonary function testing on bleomycin dosing in germ cell tumours.
    Roncolato FT; Chatfield M; Houghton B; Toner G; Stockler M; Thomson D; Friedlander M; Gurney H; Rosenthal M; Grimison P;
    Intern Med J; 2016 Aug; 46(8):893-8. PubMed ID: 27305276
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Are there sex differences in the capillary blood volume and diffusing capacity response to exercise?
    Bouwsema MM; Tedjasaputra V; Stickland MK
    J Appl Physiol (1985); 2017 Mar; 122(3):460-469. PubMed ID: 27932673
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.